Invited letter in response to "Predicted indirectly recognizable HLA epitopes (PIRCHE): Only the tip of the iceberg?"

Nils Lachmann; Matthias Niemann; Petra Reinke; Klemens Budde; Danilo Schmidt; Fabian Halleck; Axel Pruß; Constanze Schönemann; Eric Spierings; Oliver Staeck

doi:10.1111/ajt.14535

Invited letter in response to "Predicted indirectly recognizable HLA epitopes (PIRCHE): Only the tip of the iceberg?"

Am J Transplant. 2018 Feb;18(2):523-524. doi: 10.1111/ajt.14535. Epub 2017 Nov 4.

Authors

Affiliations

¹ Center for Tumor Medicine, H&I Laboratory, Charité University Medicine Berlin, Berlin, Germany.
² PIRCHE AG, Berlin, Germany.
³ Department of Nephrology, Charité University Medicine Berlin, Berlin, Germany.
⁴ Universitary Tissue Bank, Charité University Medicine Berlin, Berlin, Germany.
⁵ UMC Utrecht, Laboratory of Translational Immunology, Utrecht, The Netherlands.

PMID: 28992384
DOI: 10.1111/ajt.14535

No abstract available

Keywords: B cell biology; T cell biology; alloantibody; alloantigen; antigen presentation/recognition; clinical research/practice; histocompatibility; kidney transplantation/nephrology; organ procurement and allocation; translational research/science.

Publication types

Letter
Comment

MeSH terms

Epitopes*
HLA Antigens
Histocompatibility Testing*

Substances

Epitopes
HLA Antigens